ZnO and TiO2 nanoparticles as novel antimicrobial agents for oral hygiene: a review
Source abstract
Abstract
Oral cavity is inhabited by more than 25,000 different bacterial phylotypes; some of them cause systemic infections in addition to dental and periodontal diseases. Emergence of multiple antibiotic resistance among these bacteria necessitates the development of alternative antimicrobial agents that are safe, stable, and relatively economic. This review focuses on the significance of metal oxide nanoparticles, especially zinc oxide and titanium dioxide nanoparticles as supplementary antimicrobials for controlling oral infections and biofilm formation. Indeed, the ZnO NPs and TiO2 NPs have exhibited significant antimicrobial activity against oral bacteria at concentrations which is not toxic in in vivo toxicity assays. These nanoparticles are being produced at an industrial scale for use in a variety of commercial products including food products. Thus, the application of ZnO and TiO2 NPs as nanoantibiotics for the development of mouthwashes, dental pastes, and other oral hygiene materials is envisaged. It is also suggested that these NPs could serve as healthier, innocuous, and effective alternative for controlling both the dental biofilms and oral planktonic bacteria with lesser side effects and antibiotic resistance.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Oral microbiology and periodontitis research · Scientific and Engineering Research Topics · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE (2005) Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43:5721–573210.1128/JCM.43.11.5721-5732.2005 ↗
2. Abeylath SC, Turos E (2008) Drug delivery approaches to overcome bacterial resistance to β-lactam antibiotics. Expert Opin Drug Deliv 5:931–94910.1517/17425247.5.9.931 ↗
3. Adams PC, Walker KA, Obare SO, Docherty KM (2014) Size-dependent antimicrobial effects of novel palladium nanoparticles. PLoS ONE 9(1):e8598110.1371/journal.pone.0085981 ↗
4. Ahmad J, Dwivedi S, Alarifia S, Al-Khedhairy AA, Musarrat J (2012) Use of β-galactosidase (lacZ) gene α-complementation as a novel approach for assessment of titanium oxide nanoparticles induced mutagenesis. Mutat Res 747:246–25210.1016/j.mrgentox.2012.06.002 ↗
5. Ahn J, Chen CY, Hayes RB (2012) Oral microbiome an oral and gastrointestinal cancer risk. Cancer Cause Control 23:399–40410.1007/s10552-011-9892-7 ↗
6. Akbar A, Kumar A (2014) Zinc oxide nanoparticles loaded active packaging, a challenge study against Salmonella typhimurium and Staphylococcus aureus in ready-to-eat poultry meat. Food Control 38:88–9510.1016/j.foodcont.2013.09.065 ↗
7. Ali J, Pramod K, Tahir MA, Ansari SH (2011) Autoimmune responses in periodontal diseases. Autoimmun Rev 10:426–43110.1016/j.autrev.2010.04.005 ↗
8. Allaker RP (2010) The use of nanoparticles to control oral biofilm formation. J Dent Res 89:1175–118610.1177/0022034510377794 ↗
9. Allaker RP, Memarzadeh K (2014) Nanoparticles and the control of oral infections. Int J Antimicrob Agents 43:95–10410.1016/j.ijantimicag.2013.11.002 ↗
10. Applerot G, Lellouche J, Perkas N, Nitzan Y, Gedanken A, Banin E (2012) ZnO nanoparticle-coated surfaces inhibit bacterial biofilm formation and increase antibiotic susceptibility. RSC Adv 2:2314–232110.1039/c2ra00602b ↗
11. Ardila CM, López MA, Guzmán IC (2010) High resistance against clindamycin, metronidazole and amoxicillin in Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans isolates of periodontal disease. Med Oral Patol Oral Cir Bucal 15:e947–e95110.4317/medoral.15.e947 ↗
12. Aydin-Sevinç AB, Hanley L (2010) Antibacterial activity of dental composites containing zinc oxide nanoparticles. J Biomed Mater Res B 94:22–3110.1002/jbm.b.31620 ↗
13. Azam A, Ahmed SA, Oves M, Khan MS, Memic A (2012) Size-dependent antimicrobial properties of CuO nanoparticles against Gram-positive and -negative bacterial strains. Int J Nanomed 7:3527–353510.2147/IJN.S29020 ↗
14. Baek YW, An YJ (2011) Microbial toxicity of metal oxide nanoparticles (CuO, NiO, ZnO, and Sb2O3) to Escherichia coli, Bacillus subtilis, and Streptococcus aureus. Sci Total Environ 409:1603–160810.1016/j.scitotenv.2011.01.014 ↗
15. Balogh L, Swanson DR, Tomalia DA, Hagnauer GL, McManus AT (2001) Dendrimer-silver complexes and nanocomposites as antimicrobial agents. Nano Lett 1:18–2110.1021/nl005502p ↗
16. Bañobre-López M, Teijeiro A, Rivas J (2013) Magnetic nanoparticle-based hyperthermia for cancer treatment. Rep Pract Oncol Radiother 18:397–40010.1016/j.rpor.2013.09.011 ↗
17. Bascones-Martinez A, Matesanz-Perez P, Escribano-Bermejo M et al (2011) Periodontal disease and diabetes-review of the literature. Med Oral Patol Oral Cir Bucal 16:e722–e72910.4317/medoral.17032 ↗
18. Belda-Ferre P, Alcaraz LD, Cabrera-Rubio R et al (2011) The oral metagenome in health and disease. ISME J 6:46–5610.1038/ismej.2011.85 ↗
19. Berube DM, Searson EM, Morton TS, Cummings CL (2010) Project on emerging nanotechnologies—consumer product inventory evaluated. Nanotechnol Law Bus 7:152–163
20. Bondarenko O, Juganson K, Ivask A, Kasemets K, Mortimer M, Kahru A (2013) Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: a critical review. Arch Toxicol 87:1181–120010.1007/s00204-013-1079-4 ↗
21. Bradshaw DJ, Homer KA, Marsh PD, Beighton D (1994) Metabolic cooperation in oral microbial communities during growth on mucin. Microbiol 140:3407–341210.1099/13500872-140-12-3407 ↗
22. Bragg PD, Rainnie DJ (1974) The effect of silver ions on the respiratory chain of Escherichia coli. Can J Microbiol 20:883–88910.1139/m74-135 ↗
23. Brown MR, Allison DG, Gilbert P (1988) Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother 22:777–78010.1093/jac/22.6.777 ↗
24. Byrne GI, Kalayoglu MV (1999) Chlamydia pneumoniae and atherosclerosis: links to the disease process. Am Heart J 138:S488–S49010.1016/S0002-8703(99)70282-6 ↗
25. Cai W, Gao T, Hong H, Sun J (2008) Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl. doi: 10.2147/NSA.S3788
26. Castellarin M, Warren RL, Freeman JD et al (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22:299–30610.1101/gr.126516.111 ↗
27. Cheng L, Weir MD, Xu HH et al (2012) Effect of amorphous calcium phosphate and silver nanocomposites on dental plaque microcosm biofilms. J Biomed Mater Res B 100:1378–138610.1002/jbm.b.32709 ↗
28. Choi O, Deng KK, Kim NJ et al (2008) The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res 42:3066–307410.1016/j.watres.2008.02.021 ↗
29. Chun MJ, Shim E, Kho EH et al (2007) Surface modification of orthodontic wires with photocatalytic titanium oxide for its antiadherent and antibacterial properties. Angle Orthod 77:483–48810.2319/0003-3219(2007)077[0483:SMOOWW]2.0.CO;2 ↗
30. Clarke JK (1924) On the bacterial factor in the etiology of dental caries. Br J Exp Pathol 5:141–147
31. Cole MF, Evans M, Fitzsimmons S et al (1994) Pioneer oral Streptococci produce immunoglobulin A1 protease. Infect Immun 62:2165–216810.1128/IAI.62.6.2165-2168.1994 ↗
32. Costerton JW, Lewandowski Z, Caldwell DE et al (1995) Microbial biofilms. Annu Rev Microbiol 49:711–74510.1146/annurev.mi.49.100195.003431 ↗
33. Dar-Odeh NS, Abu-Hammad OA, Al-Omiri MK, Khraisat AS, Shehabi AA (2010) Antibiotic prescribing practices by dentists: a review. Ther Clin Risk Manag 6:301–30610.2147/TCRM.S9736 ↗
34. Darveau PR (2010) Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 8:481–49010.1038/nrmicro2337 ↗
35. Dastjerdi R, Montazer M (2010) A review on the application of inorganic nanostructured materials in the modification of textile: focus on antimicrobial properties. Colloids Surf B 79:5–1810.1016/j.colsurfb.2010.03.029 ↗
36. Davey ME, O’Toole GA (2000) Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 64:847–86710.1128/MMBR.64.4.847-867.2000 ↗
37. De Berardis B, Civitelli G, Condello M et al (2010) Exposure to ZnO nanoparticles induces oxidative stress and cytotoxicity in human colon carcinoma cells. Toxicol Appl Pharmacol 246:116–12710.1016/j.taap.2010.04.012 ↗
38. De Jong WH, Borm PJA (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3:133–14910.2147/IJN.S596 ↗
39. Deshpande RG, Khan MB, Genco CA (1998) Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 66:5337–534310.1128/IAI.66.11.5337-5343.1998 ↗
40. Dewhirst FE, Chen T, Izard J et al (2010) The human oral microbiome. J Bacteriol 192:5002–501710.1128/JB.00542-10 ↗
41. Dietrich T, Sharma P, Walter C et al (2013) The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Periodontol 84:S70–S8410.1902/jop.2013.134008 ↗
42. Drummen GPC (2010) Quantum dots—from synthesis to applications in biomedicine and life sciences. Int J Mol Sci 11:154–16310.3390/ijms11010154 ↗
43. Dwivedi P, Narvi SS, Tewari RP (2013) Application of polymer nanocomposites in the nanomedicine landscape: envisaging strategies to combat implant associated infections. J Appl Biomater Funct Mater 11:129–142
44. Eshed M, Lellouche J, Matalon S et al (2012) Sonochemical coatings of ZnO and CuO nanoparticles inhibit Streptococcus mutans biofilm formation on teeth model. Langmuir 28:12288–1229510.1021/la301432a ↗
45. Espinosa-Cristóbal FA, Martínez-Castañóna GA, Téllez-Déctorb EJ et al (2012) Adherence inhibition of Streptococcus mutans on dental enamel surface using silver nanoparticles. Mater Sci Eng C 33:2197–220210.1016/j.msec.2013.01.039 ↗
46. Fabrega J, Zhang R, Renshaw JC, Liu WT, Lead JR (2011) Impact of silver nanoparticles on natural marine biofilm bacteria. Chemosphere 85:961–96610.1016/j.chemosphere.2011.06.066 ↗
47. Fang M, Chen JH, Xu XL, Yang PH, Hildebr HF (2006) Antibacterial activities of inorganic agents on six bacteria associated with oral infections by two susceptibility tests. Int J Antimicrob Agents 27:513–51710.1016/j.ijantimicag.2006.01.008 ↗
48. Fardini Y, Wang X, Temoin S et al (2011) Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol 82:1468–148010.1111/j.1365-2958.2011.07905.x ↗
49. Fosse T, Madinier I, Hitzig C, Charbit Y (1999) Prevalence of beta-lactamase-producing strains among 149 anaerobic Gram-negative rods isolated from periodontal pockets. Oral Microbiol Immunol 14:352–35710.1034/j.1399-302X.1999.140604.x ↗
50. Frandsen EV, Theilade E, Ellegaard B, Kilian M (1986) Proportions and identity of IgA1-degrading bacteria in periodontal pockets from patients with juvenile and rapidly progressive periodontitis. J Periodontal Res 21:613–62310.1111/j.1600-0765.1986.tb01498.x ↗
51. Fröjd V, Linderbäck P, Wennerberg A, Chávez de Paz L, Svensäter G, Davies JR (2011) Effect of nanoporous TiO2 coating and anodized Ca2+ modification of titanium surfaces on early microbial biofilm formation. BMC Oral Health 11:810.1186/1472-6831-11-8 ↗
52. Fukui H, Horie M, Endoh S et al (2012) Association of zinc ion release and oxidative stress induced by intratracheal instillation of ZnO nanoparticles to rat lung. Chem Biol Interact 198:29–3710.1016/j.cbi.2012.04.007 ↗
53. Gilbert P, Das J, Foley I (1997) Biofilm susceptibility to antimicrobials. Adv Dent Res 11:160–16710.1177/08959374970110010701 ↗
54. Hajipour MJ, Fromm KM, Ashkarran AA et al (2012) Antibacterial properties of nanoparticles. Trends Biotechnol 30:499–51110.1016/j.tibtech.2012.06.004 ↗
55. Han YW, Wang X (2013) Mobile microbiome: oral bacteria in extra-oral infections and inflammation. J Dent Res 92:485–49110.1177/0022034513487559 ↗
56. Han YW, Fardini Y, Chen C et al (2010) Term stillbirth caused by oral Fusobacterium nucleatum. Obstet Gynecol 115:442–44510.1097/AOG.0b013e3181cb9955 ↗
57. Hanemann T, Szabó DV (2010) Polymer-nanoparticle composites: from synthesis to modern applications. Materials 3:3468–351710.3390/ma3063468 ↗
58. Hayashi C, Gudino CV, Gibson FCIII, Genco CA (2010) Review: pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol 25:305–31610.1111/j.2041-1014.2010.00582.x ↗
59. Hernández-Sierra JF, Ruiz F, Pena DC et al (2008) The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold. Nanomedicine 4:237–24010.1016/j.nano.2008.04.005 ↗
60. Herzberg MC, Meyer MW (1996) Effects of oral flora on platelets: possible consequences in cardiovascular disease. J Periodontol 67:1138–114210.1902/jop.1996.67.10s.1138 ↗
61. Hetrick EM, Shin JH, Paul SH, Schoenfisch MH (2009) Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 30:2782–278910.1016/j.biomaterials.2009.01.052 ↗
62. Höglund ÅC, Haubek D, Kwamin F, Johansson A, Claesson R (2014) Leukotoxic activity of Aggregatibacter actinomycetemcomitans and periodontal attachment loss. PLoS One 9(8):e10409510.1371/journal.pone.0104095 ↗
63. Hojo K, Nagaoka S, Ohshima T, Maeda N (2009) Bacterial interactions in dental biofilm development. J Dent Res 88:982–99010.1177/0022034509346811 ↗
64. Huh AJ, Kwon YJ (2011) “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Controlled Release 156:128–14510.1016/j.jconrel.2011.07.002 ↗
65. Hule RA, Pochan DJ (2007) Polymer nanocomposites for biomedical applications. MRS Bull 32:354–35810.1557/mrs2007.235 ↗
66. Ismail Y, Mahendran V, Octavia S et al (2012) Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS ONE 7:e3821710.1371/journal.pone.0038217 ↗
67. Jenkinson HF (2011) Beyond the oral microbiome. Environ Microbiol 13:3077–308710.1111/j.1462-2920.2011.02573.x ↗
68. Jin T, Sun D, Su JY, Zhang H (2009) Antimicrobial efficacy of zinc oxide quantum dots against Listeria monocytogenes, Salmonella enteritidis and E. coli O157:H7. J Food Sci 74:46–5210.1111/j.1750-3841.2008.01013.x ↗
69. Kamer AR, Dasanayake AP, Craig RG, Glodzik-Sobanska L, Bry M, de Leon MJ (2008) Alzheimer’s disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis 13:437–44910.3233/JAD-2008-13408 ↗
70. Keijser BJF, Zaura E, Huse SM et al (2008) Pyrosequencing analysis of the Oral microflora of healthy adults. J Dent Res 87:1016–102010.1177/154405910808701104 ↗
71. Keller AA, McFerran S, Lazareva A, Suh S (2013) Global life cycle releases of engineered nanomaterials. J Nanopart Res 15:169210.1007/s11051-013-1692-4 ↗
72. Khan ST, Ahmad M, Al-Khedhairy AA, Musarrat J (2013a) Biocidal effect of copper and zinc oxide nanoparticles on human oral microbiome and biofilm formation. Mater Lett 97:67–7010.1016/j.matlet.2013.01.085 ↗
73. Khan ST, Ahamed M, Alhadlaq HA, Musarrat J, Al-Khedhairy AA (2013b) Comparative effectiveness of NiCl2, Ni- and NiO-NPs in controlling oral bacterial growth and biofilm formation on oral surfaces. Arch Oral Biol 58:1804–181110.1016/j.archoralbio.2013.09.011 ↗
74. Khan M, Khan ST, Khan M et al (2014a) Antibacterial properties of silver nanoparticles synthesized using Pulicaria glutinosa plant extract as a green bioreductant. Int J Nanomed 9:3551–3565
75. Khan ST, Ahamed M, Musarrat J, Al-Khedhairy AA (2014b) Antibiofilm and antibacterial activities of zinc oxide nanoparticles against the oral opportunistic pathogens Rothia dentocariosa (Ora-7) and Rothia mucilaginosa (Ora-16) isolates. Eur J Oral Sci 122:397–40310.1111/eos.12152 ↗
76. Kim JS, Kuk E, Yu KN et al (2007) Antimicrobial effects of silver nanoparticles. Nanomedicine 3:95–10110.1016/j.nano.2006.12.001 ↗
77. Kirchner M, Mafura M, Hunt T, Card R, Anjum MF (2013) Antibiotic resistance gene profiling of faecal and oral anaerobes collected during an antibiotic challenge trial. Anaerobe 23:20–2210.1016/j.anaerobe.2013.07.011 ↗
78. Kolenbrander PE, London J (1993) Adhere today, here tomorrow: oral bacterial adherence. J Bacteriol 175:3247–325210.1128/jb.175.11.3247-3252.1993 ↗
79. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ Jr (2002) Communication among oral bacteria. Microbiol Mol Biol Rev 66:486–50510.1128/MMBR.66.3.486-505.2002 ↗
80. Kolenbrander PE, Palmer RJ, Periasamy S, Jakubovics NS (2010) Oral multispecies biofilm development and the key role of cell–cell distance. Nat Rev Microbiol 8:473–48010.1038/nrmicro2381 ↗
81. Komoria R, Sato T, Yamamotoa T, Takahashi N (2012) Microbial composition of dental plaque microflora on first molars with orthodontic bands and brackets, and the acidogenic potential of these bacteria. J Ora Biosci 54:107–11210.1016/j.job.2012.01.009 ↗
82. Konishi K (1987) Antibacterial effect of the powdered semiconductor titanium oxide on the viability of oral microorganisms. Shika Igaku 50:119–125
83. Koren O, Spor A, Felin J et al (2011) Human oral, gut, and plaque microbiota in patients with atherosclerosis. PNAS 108:4592–459810.1073/pnas.1011383107 ↗
84. Kostic AD, Chun E, Robertson L et al (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14:207–21510.1016/j.chom.2013.07.007 ↗
85. Kouidhi B, Zmantar T, Mahdouani K, Hentati H, Bakhrouf A (2011) Antibiotic resistance and adhesion properties of oral Enterococci associated to dental caries. BMC Microbiol 11:15510.1186/1471-2180-11-155 ↗
86. Kühn KP, Cahberny IF, Massholder K et al (2003) Disinfection of surfaces by photocatalytic oxidation with titanium dioxide and UVA light. Chemosphere 53:71–7710.1016/S0045-6535(03)00362-X ↗
87. Kumar A, Pandey AK, Singh SS, Shanker R, Dhawan A (2011) Engineered ZnO and TiO2 nanoparticles induce oxidative stress and DNA damage leading to reduced viability of Escherichia coli. Free Radic Biol Med 51:1872–188110.1016/j.freeradbiomed.2011.08.025 ↗
88. Lee HR, Jun HK, Kim HD, Lee SH, Choi BK (2012) Fusobacterium nucleatum GroEL induces risk factors of atherosclerosis in human microvascular endothelial cells and ApoE(−/−) mice. Mol Oral Microbiol 27:109–12310.1111/j.2041-1014.2011.00636.x ↗
89. Lee JH, Kim YG, Cho MH, Lee J (2014) ZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor production. Microbiol Res 169:888–89610.1016/j.micres.2014.05.005 ↗
90. Leistevuo J, Järvinen H, Österblad M, Leistevuo T, Huovinen P, Tenovuo J (2000) Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings. Antimicrob Agents Chemother 44:456–45710.1128/AAC.44.2.456-457.2000 ↗
91. Li X, Kolltveit KM, Tronstad L, Olsen I (2000) Systemic diseases caused by oral infection. Clin Microbiol Rev 13:547–55810.1128/CMR.13.4.547-558.2000 ↗
92. Li Q, Mahendra S, Lyon DY et al (2008) Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. Water Res 42:4591–460210.1016/j.watres.2008.08.015 ↗
93. Li K, Zhao X, Hammer BK, Du S, Chen Y (2013) Nanoparticles inhibit DNA replication by binding to DNA: modeling and experimental validation. ACS Nano 7:9664–967410.1021/nn402472k ↗
94. Liu Y, He L, Mustapha A, Li H, Hu ZQ, Lin M (2009) Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7. J Appl Microbiol 107:1193–120110.1111/j.1365-2672.2009.04303.x ↗
95. Liu B, Faller LL, Klitgord N et al (2012) Deep sequencing of the oral microbiome reveals signatures of periodontal disease. PLoS ONE 7(1–16):e3791910.1371/journal.pone.0037919 ↗
96. Loesche WJ (1986) Role of Streptococcus mutans in human dental decay. Microbiol Rev 50(4):353–38010.1128/MMBR.50.4.353-380.1986 ↗
97. Lu Z, Rong K, Li J, Yang H, Chen R (2013) Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria. J Mater Sci Mater Med 24:1465–147110.1007/s10856-013-4894-5 ↗
98. Luo Morrin A, Killard AJ, Smyth MR (2006) Application of nanoparticles in electrochemical sensors and biosensors. Electroanalysis 18:319–32610.1002/elan.200503415 ↗
99. Madinier IM (1999) Resistance profile survey of 50 periodontal strains of Actinobacillus actinomycetemcomitans. J Periodontol 70:888–89210.1902/jop.1999.70.8.888 ↗
100. Mah TFC, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9:34–3910.1016/S0966-842X(00)01913-2 ↗